CHI3L1 and cardiovascular disorder: The non-specificity of YKL-40 expression in various age-related pathological conditions, including neoplastic and cardiovascular diseases, as well as inflammatory disorders of different etiologies, poses a constraint on its future application as a biomarker in the older adult population [84, 162].